bims-mricoa
Biomed News
on MRI contrast agents
Issue of
2022–04–10
two papers selected by
Merve Yavuz
,
Bilkent University
Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective.
Author Correction: Engineered promoters enable constant gene expression at any copy number in bacteria.
Kidney360. 2020 Jun 25. 1(6): 433-435
Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective.
Michael R Rudnick
,
Ihab M Wahba
,
Amanda K Leonberg-Yoo
.
Keywords:
chronic kidney disease; clinical nephrology; gadolinium-based contrast agents; magnetic resonance imaging; nephrogenic systemic fibrosis
DOI:
https://doi.org/10.34067/KID.0003022020
Nat Biotechnol. 2022 Apr 07.
Author Correction: Engineered promoters enable constant gene expression at any copy number in bacteria.
Thomas H Segall-Shapiro
,
Eduardo D Sontag
,
Christopher A Voigt
.
DOI:
https://doi.org/10.1038/s41587-022-01300-7